Synopsis : Indian equity markets opened lower on Thursday as broad-based selling dragged the Sensex down over 400 points and pushed the Nifty below 25,900. Despite U.S. President Donald Trump’s softer stance on China tariffs, investor sentiment remained cautious across key sectors.
The Indian stock market witnessed a sharp decline on Thursday amid global uncertainty and profit booking across sectors. The BSE Sensex slipped 436 points (0.51%) to 84,561, while the NSE Nifty 50 dropped 124 points (0.48%) to 25,930, testing key psychological support levels.
Broader indices followed the benchmark’s trend — the Nifty MidCap index fell 0.47%, and the Nifty SmallCap index declined 0.31%, reflecting subdued investor appetite beyond large-cap counters.
Market weakness was led by heavyweights such as Bharti Airtel, Sun Pharma, ITC, Tata Steel, Power Grid, Reliance Industries, Titan, Kotak Bank, Infosys, Axis Bank, Trent, and HCL Tech, all shedding up to 2%. On the other hand, only Larsen & Toubro (L&T) and Maruti Suzuki managed to stay in positive territory, offering mild support to an otherwise weak market.
Among sectors, the Nifty Pharma index emerged as the top loser, plunging 1.4%, followed by declines in Metal (-0.9%), FMCG (-0.4%), and Private Bank (-0.6%) indices. The widespread correction indicates broad-based selling pressure amid cautious positioning ahead of global policy cues.
In international developments, optimism emerged after U.S. President Donald Trump revealed that he had a “great meeting” with Chinese Premier Xi Jinping. Trump announced plans to reduce tariffs on China to 47% from 57% and confirmed that a new trade deal will be signed soon. He also noted that China will resume soybean purchases and maintain exports of rare earth materials, signaling a potential easing of trade tensions.
However, Indian markets failed to pick up the global optimism, as domestic investors remained focused on earnings results, fund outflows, and rising volatility ahead of the U.S. Federal Reserve’s policy update.
Disclaimer : This article is for informational purposes only and does not constitute financial or investment advice. Readers are encouraged to consult professional financial advisors before making any investment decisions.
